Sichuan Jinshi Technology Co.,Ltd (SHE:002951)
China · Delayed Price · Currency is CNY 15.43
-0.67 (-4.16%)
Aug 1, 2025, 3:04 PM CST
Revance Therapeutics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 405.37 | 371.84 | 29.86 | 182.97 | 374.7 | 626.28 | Upgrade |
Other Revenue | 3.98 | 3.98 | 4.04 | 1.65 | 12.29 | 13.15 | Upgrade |
| 409.36 | 375.82 | 33.91 | 184.62 | 386.99 | 639.43 | Upgrade | |
Revenue Growth (YoY) | 5063.89% | 1008.39% | -81.63% | -52.29% | -39.48% | 9.37% | Upgrade |
Cost of Revenue | 372.02 | 340.78 | 27.46 | 143.1 | 262.08 | 392.54 | Upgrade |
Gross Profit | 37.34 | 35.04 | 6.45 | 41.52 | 124.92 | 246.89 | Upgrade |
Selling, General & Admin | 70.59 | 68.87 | 54.56 | 33.9 | 31.59 | 28.91 | Upgrade |
Research & Development | 25.74 | 21.73 | 11.13 | 12.79 | 10.44 | 11.01 | Upgrade |
Other Operating Expenses | 6.08 | 5.42 | 4.99 | 5.31 | 6.86 | 0.87 | Upgrade |
Operating Expenses | 118.32 | 112.3 | 69.59 | 51.83 | 45.07 | 38.83 | Upgrade |
Operating Income | -80.98 | -77.26 | -63.14 | -10.31 | 79.85 | 208.06 | Upgrade |
Interest Expense | -0.12 | -0.19 | -0.04 | - | - | - | Upgrade |
Interest & Investment Income | 110.02 | 112.46 | 8.36 | 11.66 | 8.4 | 18.43 | Upgrade |
Other Non Operating Income (Expenses) | 0.57 | 0.46 | -0.18 | -0.32 | 0.11 | -5.11 | Upgrade |
EBT Excluding Unusual Items | 29.49 | 35.47 | -55 | 1.03 | 88.36 | 221.38 | Upgrade |
Impairment of Goodwill | -17.34 | -17.34 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -13.99 | -0.97 | -15.67 | -4.74 | 1.59 | 0.36 | Upgrade |
Gain (Loss) on Sale of Assets | 7.31 | 7.47 | 30.48 | 1.48 | 1.56 | 0 | Upgrade |
Asset Writedown | -1.37 | -1.24 | -14.86 | -36.33 | -29.25 | -0.19 | Upgrade |
Other Unusual Items | -19.91 | -19.9 | -0.43 | 0.47 | 1.76 | - | Upgrade |
Pretax Income | -15.8 | 3.49 | -55.47 | -38.09 | 64.02 | 221.55 | Upgrade |
Income Tax Expense | 18.27 | 19.72 | -7 | 1.98 | 8.96 | 32.36 | Upgrade |
Earnings From Continuing Operations | -34.07 | -16.22 | -48.47 | -40.07 | 55.06 | 189.18 | Upgrade |
Minority Interest in Earnings | 10.48 | 11.83 | 3.9 | 3.48 | 0.68 | - | Upgrade |
Net Income | -23.6 | -4.4 | -44.57 | -36.59 | 55.74 | 189.18 | Upgrade |
Net Income to Common | -23.6 | -4.4 | -44.57 | -36.59 | 55.74 | 189.18 | Upgrade |
Net Income Growth | - | - | - | - | -70.54% | 4.86% | Upgrade |
Shares Outstanding (Basic) | 469 | 440 | 405 | 407 | 398 | 403 | Upgrade |
Shares Outstanding (Diluted) | 469 | 440 | 405 | 407 | 398 | 403 | Upgrade |
Shares Change (YoY) | 23.33% | 8.52% | -0.33% | 2.11% | -1.09% | 2.63% | Upgrade |
EPS (Basic) | -0.05 | -0.01 | -0.11 | -0.09 | 0.14 | 0.47 | Upgrade |
EPS (Diluted) | -0.05 | -0.01 | -0.11 | -0.09 | 0.14 | 0.47 | Upgrade |
EPS Growth | - | - | - | - | -70.21% | 2.17% | Upgrade |
Free Cash Flow | -311.23 | -278.52 | -99.34 | -43.73 | 65.43 | 6.81 | Upgrade |
Free Cash Flow Per Share | -0.66 | -0.63 | -0.24 | -0.11 | 0.16 | 0.02 | Upgrade |
Dividend Per Share | 1.000 | 1.000 | - | - | 0.050 | 0.150 | Upgrade |
Dividend Growth | - | - | - | - | -66.67% | -76.92% | Upgrade |
Gross Margin | 9.12% | 9.32% | 19.02% | 22.49% | 32.28% | 38.61% | Upgrade |
Operating Margin | -19.78% | -20.56% | -186.23% | -5.59% | 20.63% | 32.54% | Upgrade |
Profit Margin | -5.76% | -1.17% | -131.45% | -19.82% | 14.40% | 29.59% | Upgrade |
Free Cash Flow Margin | -76.03% | -74.11% | -292.97% | -23.69% | 16.91% | 1.06% | Upgrade |
EBITDA | -52.62 | -50.22 | -41.41 | 21.24 | 122.93 | 253.04 | Upgrade |
EBITDA Margin | -12.85% | -13.36% | -122.13% | 11.50% | 31.77% | 39.57% | Upgrade |
D&A For EBITDA | 28.36 | 27.04 | 21.73 | 31.55 | 43.08 | 44.98 | Upgrade |
EBIT | -80.98 | -77.26 | -63.14 | -10.31 | 79.85 | 208.06 | Upgrade |
EBIT Margin | -19.78% | -20.56% | -186.23% | -5.59% | 20.63% | 32.54% | Upgrade |
Effective Tax Rate | - | 564.46% | - | - | 14.00% | 14.61% | Upgrade |
Revenue as Reported | 409.36 | 375.82 | 33.91 | 184.62 | 386.99 | 639.43 | Upgrade |
Advertising Expenses | - | 0.68 | - | - | - | - | Upgrade |
Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.